StockMacro
Company, fund or insider

Help

Menu

ALX Oncology

$1.06 -45% in 6 monthsMarket cap $137.0M

ALXO on XNAS, Health Care, ALX Oncology Holdings Inc., job postings

Measures activity, not value. Not investment advice.

Short interest reached 7.6M shares, 4.7 times a year earlier, as the company lost $80.6M in 12 months.

  • GoodInstitutional holders rose to 108 from 92, up 17% in a quarter
  • BadFree cash outflow of $68.6M over 12 months against $147.2M cash

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Industry
Pharmaceutical preparations (Health Care)
Employees
49
Website
alxoncology.com
Listed
Nasdaq, US
Last results
16 Nov 2026
Next results
expected around 26 Feb 2027 (an estimate: a year ago it reported on 27 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: net loss $21.8M.
Quarter to 31 Dec 2021: revenue –, net income -$28.4MQuarter to 31 Mar 2022: revenue –, net income -$24.5MQuarter to 30 Jun 2022: revenue –, net income -$32.9MQuarter to 30 Sep 2022: revenue –, net income -$35.3MQuarter to 31 Dec 2022: revenue –, net income -$30.7MQuarter to 31 Mar 2023: revenue –, net income -$30.2MQuarter to 30 Jun 2023: revenue –, net income -$34.2MQuarter to 30 Sep 2023: revenue –, net income -$51.0MQuarter to 31 Dec 2023: revenue –, net income -$45.5MQuarter to 31 Mar 2024: revenue –, net income -$35.6MQuarter to 30 Jun 2024: revenue –, net income -$39.4MQuarter to 30 Sep 2024: revenue –, net income -$30.7MQuarter to 31 Dec 2024: revenue –, net income -$29.2MQuarter to 31 Mar 2025: revenue –, net income -$30.8MQuarter to 30 Jun 2025: revenue –, net income -$25.9MQuarter to 30 Sep 2025: revenue –, net income -$22.1MQuarter to 31 Dec 2025: revenue –, net income -$22.8MQuarter to 31 Mar 2026: revenue –, net income -$17.9MQuarter to 30 Jun 2026: revenue –, net income -$18.0MQuarter to 30 Sep 2026: revenue –, net income -$21.8M
31 Dec 2021RevenueNet incomeNet losstallest bar $51.0M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026–-$21.8M
30 Jun 2026–-$18.0M
31 Mar 2026–-$17.9M
31 Dec 2025–-$22.8M
30 Sep 2025–-$22.1M
30 Jun 2025–-$25.9M
31 Mar 2025–-$30.8M
31 Dec 2024–-$29.2M
30 Sep 2024–-$30.7M
30 Jun 2024–-$39.4M
31 Mar 2024–-$35.6M
31 Dec 2023–-$45.5M
30 Sep 2023–-$51.0M
30 Jun 2023–-$34.2M
31 Mar 2023–-$30.2M
31 Dec 2022–-$30.7M
30 Sep 2022–-$35.3M
30 Jun 2022–-$32.9M
31 Mar 2022–-$24.5M
31 Dec 2021–-$28.4M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. – –
Revenue growthRevenue of the last 12 months compared with the 12 months before. – +11%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$80.6M -$108.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$0.87 -$2.01
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 73.2%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. – – -25.0%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. – – -18.2%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -94.4% -58.8%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. -$68.6M -$97.4M
CashCash, cash equivalents and short-term investments on the latest balance sheet. $147.2M $60.6M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. $10.2M $10.6M
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). -$137.0M (net cash) -$50.0M
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. 0.08 0.0
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $0.97
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 19.3
P/SPrice to sales: market cap divided by revenue of the last 12 months. – 5.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 5.0
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 1.1 2.0

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
ALX OncologyALXO (this company) $137.0Mloss–––
Zentalis PharmaceuticalsZNTL $133.6Mloss–––
BridgeBio Oncology TherapeuticsBBOT $145.3Mloss–––
Sionna TherapeuticsSION $127.8Mloss–––
Atrium TherapeuticsRNA $149.3M––––
MacroGenicsMGNX $125.3Mloss1.1+23%-45.4%

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+17%

108 13F filers vs 92

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

80%

103.8M shares held by 13F filers (30 Sep 2026) of 129.3M outstanding (9 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.8%

6.2M shares sold short (30 Oct 2026) of 129.3M outstanding (9 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

4.4

6.2M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+3.2%

6.0M shares sold short in the report before, 6.2M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

56%

56% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 42%

News Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

9

9 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

9 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Unusual now sharp changes in the last 90 days, compared with its own past

  • Short interest 7.6M, 4.7× a year earlier

Price $1.06 on 20 Nov 2026, -22% over 12 months (12-month range $0.89 to $2.60)

  • Sharp change
  • 8-K and other filings
Insider net buying (open market). Insiders bought a net $5.0M in the last 12 months (the 12 months before: $173K).
Capital spending per quarter. Capital spending $65K in the latest quarter, +16% on a year earlier.
Institutional holders (13F filers). 108 13F filers reported holding it in the latest 13F quarter, +80% on a year earlier.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, revenue per quarter, federal obligations, lobbying spend, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
27 Oct 2026Sharp changeShort interest spike: short interest spike, 6.0M vs usual 1.9M (2026-10-15); 3.2x the same period a year earlier
13 Oct 2026Sharp changeShort interest spike: short interest spike, 5.7M vs usual 1.8M (2026-09-30); 4.2x the same period a year earlier
29 Sep 2026Sharp changeShort interest spike: short interest spike, 6.3M vs usual 1.7M (2026-09-15); 4.0x the same period a year earlier
15 Sep 2026Sharp changeShort interest spike: short interest spike, 7.1M vs usual 1.7M (2026-08-31); 3.9x the same period a year earlier
1 Sep 2026Sharp changeShort interest spike: short interest spike, 7.6M vs usual 1.7M (2026-08-14); 4.7x the same period a year earlier
18 Aug 2026Sharp changeShort interest spike: short interest spike, 7.7M vs usual 1.7M (2026-07-31); 1.7x the same period a year earlier
30 Jun 20268-K and other filingsDirector or officer change
26 Jun 20268-K and other filingsA major agreement ended
13 Apr 20268-K and other filingsDirector or officer change
21 Jan 20268-K and other filingsDirector or officer change
21 Jan 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Sep 20258-K and other filingsDirector or officer change
12 Aug 20258-K and other filingsDirector or officer change
12 Aug 2025Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
25 Apr 20258-K and other filingsDelisting notice or listing transfer
5 Mar 20258-K and other filingsDirector or officer change
5 Mar 20258-K and other filingsRestructuring costs announced
22 Jan 20258-K and other filingsDirector or officer change
17 Jan 20258-K and other filingsDirector or officer change
19 Nov 2024Sharp changeShort interest spike: short interest spike, 7.8M vs usual 3.9M (2024-10-31); 2.1x the same period a year earlier
14 Nov 20248-K and other filingsDirector or officer change
7 Nov 20248-K and other filingsDirector or officer change
29 Oct 2024Sharp changeShort interest spike: short interest spike, 9.6M vs usual 3.9M (2024-10-15); 2.5x the same period a year earlier
15 Oct 2024Sharp changeShort interest spike: short interest spike, 9.3M vs usual 3.8M (2024-09-30); 3.5x the same period a year earlier
4 Oct 20248-K and other filingsDirector or officer change
1 Oct 2024Sharp changeShort interest spike: short interest spike, 10.0M vs usual 3.7M (2024-09-13); 3.3x the same period a year earlier
17 Sep 2024Sharp changeShort interest spike: short interest spike, 10.0M vs usual 3.7M (2024-08-30); 3.2x the same period a year earlier
27 Aug 2024Sharp changeShort interest spike: short interest spike, 9.3M vs usual 3.7M (2024-08-15); 3.1x the same period a year earlier
13 Aug 2024Sharp changeShort interest spike: short interest spike, 9.1M vs usual 3.6M (2024-07-31); 3.1x the same period a year earlier
6 Aug 20248-K and other filingsDirector or officer change
6 Aug 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
30 Jul 2024Sharp changeShort interest spike: short interest spike, 7.8M vs usual 3.5M (2024-07-15); 2.7x the same period a year earlier
2 May 20248-K and other filingsDirector or officer change
2 May 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
6 Sep 20238-K and other filingsDirector or officer change
6 Sep 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Nov 20228-K and other filingsDirector or officer change
29 Nov 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
12 Apr 2022Sharp changeShort interest spike: short interest spike, 4.4M vs usual 2.4M (2022-03-31); 1.9x the same period a year earlier
12 Apr 20228-K and other filingsDirector or officer change
12 Apr 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Mar 2022Sharp changeShort interest spike: short interest spike, 4.1M vs usual 2.3M (2022-03-15); 3.2x the same period a year earlier
15 Mar 2022Sharp changeShort interest spike: short interest spike, 4.0M vs usual 2.3M (2022-02-28); 4.0x the same period a year earlier
1 Mar 2022Sharp changeShort interest spike: short interest spike, 4.4M vs usual 2.3M (2022-02-15); 5.6x the same period a year earlier
15 Feb 2022Sharp changeShort interest spike: short interest spike, 3.9M vs usual 2.3M (2022-01-31); 4.1x the same period a year earlier
1 Feb 2022Sharp changeShort interest spike: short interest spike, 4.4M vs usual 2.2M (2022-01-14); 3.8x the same period a year earlier
28 Dec 2021Sharp changeShort interest spike: short interest spike, 3.8M vs usual 2.2M (2021-12-15); 5.8x the same period a year earlier
Insider net buying (open market)
Month from 1 Nov 2021: -$547K published
Month from 1 Dec 2021: -$13.9M published
Month from 1 Jan 2023: -$69K published
Month from 1 Jul 2023: -$93K published
Month from 1 Jan 2024: -$245K published
Month from 1 Mar 2024: $50K published
Month from 1 Apr 2024: -$933K published
Month from 1 May 2024: -$510K published
Month from 1 Jun 2024: -$66K published
Month from 1 Jul 2024: -$258K published
Month from 1 Aug 2024: -$10K published
Month from 1 Dec 2024: $46K published
Month from 1 Jan 2025: -$23K published
Month from 1 Feb 2025: -$5K published
Month from 1 Jul 2025: -$2K published
Month from 1 Aug 2025: $57K published
Month from 1 Sep 2025: $99K published
Month from 1 Jan 2026: -$4K published
Month from 1 Feb 2026: $5.0M published
Month from 1 Mar 2026: -$29K published
Month from 1 Jul 2026: -$3K published
Month from 1 Aug 2026: -$5K published
Capital spending per quarter
Quarter ended 31 Dec 2021: $261K, +2273% on a year earlier; public on 1 Mar 2022
Quarter ended 31 Mar 2022: $589K, +8314% on a year earlier; public on 10 May 2022
Quarter ended 30 Jun 2022: $257K; public on 9 Aug 2022
Quarter ended 30 Sep 2022: $192K, -52% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $389K, +49% on a year earlier; public on 10 Mar 2023
Quarter ended 31 Mar 2023: $690K, +17% on a year earlier; public on 12 May 2023
Quarter ended 31 Dec 2023: $148K, -62% on a year earlier; public on 8 Mar 2024
Quarter ended 31 Mar 2024: $148K, -79% on a year earlier; public on 10 May 2024
Quarter ended 30 Jun 2024: $90K; public on 13 Aug 2024
Quarter ended 30 Sep 2024: $149K; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $60K, -59% on a year earlier; public on 7 Mar 2025
Quarter ended 31 Mar 2025: $60K, -59% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $47K, -48% on a year earlier; public on 13 Aug 2025
Quarter ended 30 Sep 2025: $56K, -62% on a year earlier; public on 8 Nov 2025
Quarter ended 31 Dec 2025: $49K, -18% on a year earlier; public on 10 Mar 2026
Quarter ended 31 Mar 2026: $50K, -17% on a year earlier; public on 9 May 2026
Quarter ended 30 Jun 2026: $17K, -64% on a year earlier; public on 7 Aug 2026
Quarter ended 30 Sep 2026: $65K, +16% on a year earlier; public on 17 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 101; public on 14 Feb 2022
31 Mar 2022 report: 94; public on 16 May 2022
30 Jun 2022 report: 94; public on 15 Aug 2022
30 Sep 2022 report: 92; public on 14 Nov 2022
31 Dec 2022 report: 81; public on 14 Feb 2023
31 Mar 2023 report: 83; public on 15 May 2023
30 Jun 2023 report: 70; public on 14 Aug 2023
30 Sep 2023 report: 73; public on 14 Nov 2023
31 Dec 2023 report: 88; public on 14 Feb 2024
31 Mar 2024 report: 103; public on 15 May 2024
30 Jun 2024 report: 105; public on 14 Aug 2024
30 Sep 2024 report: 90; public on 14 Nov 2024
31 Dec 2024 report: 86; public on 14 Feb 2025
31 Mar 2025 report: 82; public on 15 May 2025
30 Jun 2025 report: 59; public on 14 Aug 2025
30 Sep 2025 report: 60; public on 14 Nov 2025
31 Dec 2025 report: 54; public on 17 Feb 2026
31 Mar 2026 report: 68; public on 15 May 2026
30 Jun 2026 report: 92; public on 14 Aug 2026
30 Sep 2026 report: 108; public on 16 Nov 2026

What is unusual now

  • Made public in the last 90 days: it had 7.6M shares sold short in the 14 Aug 2026 report, 4.7× the same report last year; it also had 7.1M shares sold short in the 31 Aug 2026 report, 3.9× the same report last year. 5 sharp changes in all.
  • Short interest spike: had 7.6M shares sold short in the 14 Aug 2026 report, 4.7× the same report last year Public on 26 Aug 2026.
  • Insider net buying (open market): Insiders bought a net $5.0M in the last 12 months (the 12 months before: $173K).
  • Capital spending per quarter: Capital spending $65K in the latest quarter, +16% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 87 insider trades

No trades in the last 90 days; the latest was filed 18 Aug 2026. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
18 Aug 2026Jason LettmannCHIEF EXECUTIVE OFFICERSell2,230$1.93$4KForm 4
18 Aug 2026Shelly WongSVP, FINANCE AND CAOSell573$1.93$1KForm 4
6 Jul 2026Shelly WongSVP, FINANCE AND CAOSell1,404$2.04$3KForm 4
23 Mar 2026Jason LettmannCHIEF EXECUTIVE OFFICERSell12,311$2.17$27KForm 4
23 Mar 2026Shelly PintoSVP, FINANCE AND CAOSell903$2.17$2KForm 4
20 Feb 2026Shelly PintoSVP, FINANCE AND CAOSell565$2.27$1KForm 4
4 Feb 2026Corey S GoodmanDirector, 10% ownerBuy3,184,713$1.57$5.0MForm 4
7 Jan 2026Shelly PintoSVP, FINANCE AND CAOSell3,925$1.11$4KForm 4

108 institutions reported shares at the end of Q3 2026, 80% of the shares outstanding; 18 opened a position, 4 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Ra Capital Management, L.P.13.0M10.1%$18.1MNo change
venBio Partners LLC12.9M9.97%$17.9MNo change
BlackRock, Inc.7.7M5.97%$10.7M+313K+4.2%
Redmile Group, LLC7.2M5.56%$10.0M-207K-2.8%
Blackstone Inc.6.8M5.24%$9.4M+182K+2.8%
Silverarc Capital Management, LLC6.6M5.08%$9.1M+821K+14%
Driehaus Capital Management LLC6.0M4.66%$8.4MNo change
Vanguard Capital Management LLC4.7M3.67%$6.6M-225K-4.5%
Marshall Wace, LLP3.1M2.44%$4.4M+77K+2.5%
5AM Venture Management, LLC3.1M2.36%$4.2MNo change

Company events

All 34 company events

In 12 months: 3 director or officer changes, 3 major agreements, 1 agreement ended. Results releases and routine reports are left out.

FiledWhat happenedSource
15 Oct 2026Signed a major agreementSame filing: sold shares privately8-K
30 Jun 2026Director or officer change8-K
26 Jun 2026Signed a major agreement; A major agreement endedSame filing: took on new debt8-K
13 Apr 2026Director or officer change8-K
30 Jan 2026Signed a major agreement8-K
21 Jan 2026Director or officer change8-K
12 Sep 2025Director or officer change8-K
12 Aug 2025Director or officer change8-K

The 5 newest of 47 articles that name the company.

Timeline
Kind of data

Timeline

Changes and notable records, by the date each became public

  1. 27 Oct 2026Short interest and volume change

    had 6.0M shares sold short in the 15 Oct 2026 report, 3.2× the same report last year.

    Same report last year: 1.9M; its normal report is 1.9M.

    See the evidence
    This period
    6.0M (the 15 Oct 2026 report)
    Normal report (median of 24 earlier)
    1.9M
    Typical spread (median absolute deviation)
    727K
    How far from its usual level
    +3.8
    Same report last year
    1.9M
    History used
    2,267 days
    2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 1.8M2025-11-28: 794K2025-12-15: 1.0M2025-12-31: 985K2026-01-15: 1.1M2026-01-30: 1.1M2026-02-13: 1.2M2026-02-27: 1.2M2026-03-13: 1.2M2026-03-31: 2.2M2026-04-15: 2.0M2026-04-30: 2.2M2026-05-15: 1.4M2026-05-29: 1.7M2026-06-15: 2.6M2026-06-30: 6.3M2026-07-15: 7.5M2026-07-31: 7.7M2026-08-14: 7.6M2026-08-31: 7.1M2026-09-15: 6.3M2026-09-30: 5.7M2026-10-15: 6.0M
    the 15 Oct 2026 report24 earlier reportsnormal: 1.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  2. 10 Oct 2026Short interest and volume change

    had 5.7M shares sold short in the 30 Sep 2026 report, 4.2× the same report last year.

    Same report last year: 1.3M; its normal report is 1.8M.

    See the evidence
    This period
    5.7M (the 30 Sep 2026 report)
    Normal report (median of 24 earlier)
    1.8M
    Typical spread (median absolute deviation)
    659K
    How far from its usual level
    +4.0
    Same report last year
    1.3M
    History used
    2,252 days
    2025-09-30: 1.3M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 1.8M2025-11-28: 794K2025-12-15: 1.0M2025-12-31: 985K2026-01-15: 1.1M2026-01-30: 1.1M2026-02-13: 1.2M2026-02-27: 1.2M2026-03-13: 1.2M2026-03-31: 2.2M2026-04-15: 2.0M2026-04-30: 2.2M2026-05-15: 1.4M2026-05-29: 1.7M2026-06-15: 2.6M2026-06-30: 6.3M2026-07-15: 7.5M2026-07-31: 7.7M2026-08-14: 7.6M2026-08-31: 7.1M2026-09-15: 6.3M2026-09-30: 5.7M
    the 30 Sep 2026 report24 earlier reportsnormal: 1.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  3. 25 Sep 2026Short interest and volume change

    had 6.3M shares sold short in the 15 Sep 2026 report, 4.0× the same report last year.

    Same report last year: 1.6M; its normal report is 1.7M.

    See the evidence
    This period
    6.3M (the 15 Sep 2026 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    570K
    How far from its usual level
    +5.4
    Same report last year
    1.6M
    History used
    2,237 days
    2025-09-15: 1.6M2025-09-30: 1.3M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 1.8M2025-11-28: 794K2025-12-15: 1.0M2025-12-31: 985K2026-01-15: 1.1M2026-01-30: 1.1M2026-02-13: 1.2M2026-02-27: 1.2M2026-03-13: 1.2M2026-03-31: 2.2M2026-04-15: 2.0M2026-04-30: 2.2M2026-05-15: 1.4M2026-05-29: 1.7M2026-06-15: 2.6M2026-06-30: 6.3M2026-07-15: 7.5M2026-07-31: 7.7M2026-08-14: 7.6M2026-08-31: 7.1M2026-09-15: 6.3M
    the 15 Sep 2026 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  4. 11 Sep 2026Short interest and volume change

    had 7.1M shares sold short in the 31 Aug 2026 report, 3.9× the same report last year.

    Same report last year: 1.8M; its normal report is 1.7M.

    See the evidence
    This period
    7.1M (the 31 Aug 2026 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    544K
    How far from its usual level
    +6.6
    Same report last year
    1.8M
    History used
    2,222 days
    2025-08-29: 1.8M2025-09-15: 1.6M2025-09-30: 1.3M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 1.8M2025-11-28: 794K2025-12-15: 1.0M2025-12-31: 985K2026-01-15: 1.1M2026-01-30: 1.1M2026-02-13: 1.2M2026-02-27: 1.2M2026-03-13: 1.2M2026-03-31: 2.2M2026-04-15: 2.0M2026-04-30: 2.2M2026-05-15: 1.4M2026-05-29: 1.7M2026-06-15: 2.6M2026-06-30: 6.3M2026-07-15: 7.5M2026-07-31: 7.7M2026-08-14: 7.6M2026-08-31: 7.1M
    the 31 Aug 2026 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  5. 26 Aug 2026Short interest and volume change

    had 7.6M shares sold short in the 14 Aug 2026 report, 4.7× the same report last year.

    Same report last year: 1.6M; its normal report is 1.7M.

    See the evidence
    This period
    7.6M (the 14 Aug 2026 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    496K
    How far from its usual level
    +8.1
    Same report last year
    1.6M
    History used
    2,205 days
    2025-08-15: 1.6M2025-08-29: 1.8M2025-09-15: 1.6M2025-09-30: 1.3M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 1.8M2025-11-28: 794K2025-12-15: 1.0M2025-12-31: 985K2026-01-15: 1.1M2026-01-30: 1.1M2026-02-13: 1.2M2026-02-27: 1.2M2026-03-13: 1.2M2026-03-31: 2.2M2026-04-15: 2.0M2026-04-30: 2.2M2026-05-15: 1.4M2026-05-29: 1.7M2026-06-15: 2.6M2026-06-30: 6.3M2026-07-15: 7.5M2026-07-31: 7.7M2026-08-14: 7.6M
    the 14 Aug 2026 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  6. 12 Aug 2026Short interest and volume change

    had 7.7M shares sold short in the 31 Jul 2026 report, 1.7× the same report last year.

    Same report last year: 4.5M; its normal report is 1.7M.

    See the evidence
    This period
    7.7M (the 31 Jul 2026 report)
    Normal report (median of 24 earlier)
    1.7M
    Typical spread (median absolute deviation)
    496K
    How far from its usual level
    +8.2
    Same report last year
    4.5M
    History used
    2,191 days
    2025-07-31: 4.5M2025-08-15: 1.6M2025-08-29: 1.8M2025-09-15: 1.6M2025-09-30: 1.3M2025-10-15: 1.9M2025-10-31: 1.8M2025-11-14: 1.8M2025-11-28: 794K2025-12-15: 1.0M2025-12-31: 985K2026-01-15: 1.1M2026-01-30: 1.1M2026-02-13: 1.2M2026-02-27: 1.2M2026-03-13: 1.2M2026-03-31: 2.2M2026-04-15: 2.0M2026-04-30: 2.2M2026-05-15: 1.4M2026-05-29: 1.7M2026-06-15: 2.6M2026-06-30: 6.3M2026-07-15: 7.5M2026-07-31: 7.7M
    the 31 Jul 2026 report24 earlier reportsnormal: 1.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  7. 30 Jun 2026Filings record

    Director or officer change

  8. 26 Jun 2026Filings record

    A major agreement ended

  9. 13 Apr 2026Filings record

    Director or officer change

  10. 5 Feb 2026Insiders record

    GOODMAN COREY S (director) bought 3,184,713 shares of ALXO ($5.0M) (dated 4 Feb 2026)

  11. 21 Jan 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  12. 21 Jan 2026Filings record

    Director or officer change

  13. 19 Sep 2025Insiders record

    Lettmann Jason (CHIEF EXECUTIVE OFFICER) bought 92,233 shares of ALXO ($99,401) (dated 18 Sep 2025)

  14. 12 Sep 2025Filings record

    Director or officer change

  15. 21 Aug 2025Insiders record

    Shantharam Harish (Chief Financial Officer) bought 75,000 shares of ALXO ($58,500) (dated 20 Aug 2025)

  16. 12 Aug 2025Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  17. 12 Aug 2025Filings record

    Director or officer change

  18. 25 Apr 2025Filings record

    Delisting notice or listing transfer

  19. 5 Mar 2025Filings record

    Director or officer change

  20. 5 Mar 2025Filings record

    Restructuring costs announced

  21. 22 Jan 2025Filings record

    Director or officer change

  22. 17 Jan 2025Filings record

    Director or officer change

  23. 5 Dec 2024Insiders record

    Hemrajani Rekha (director) bought 30,000 shares of ALXO ($46,500) (dated 4 Dec 2024)

  24. 14 Nov 2024Filings record

    Director or officer change

  25. 13 Nov 2024Short interest and volume change

    had 7.8M shares sold short in the 31 Oct 2024 report, 2.1× the same report last year.

    Same report last year: 3.8M; its normal report is 3.9M.

    See the evidence
    This period
    7.8M (the 31 Oct 2024 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    602K
    How far from its usual level
    +4.5
    Same report last year
    3.8M
    History used
    1,553 days
    2023-10-31: 3.8M2023-11-15: 3.9M2023-11-30: 3.9M2023-12-15: 4.0M2023-12-29: 3.8M2024-01-12: 3.7M2024-01-31: 3.6M2024-02-15: 3.5M2024-02-29: 3.5M2024-03-15: 2.9M2024-03-28: 3.1M2024-04-15: 3.7M2024-04-30: 3.2M2024-05-15: 3.4M2024-05-31: 2.9M2024-06-14: 4.2M2024-06-28: 5.5M2024-07-15: 7.8M2024-07-31: 9.1M2024-08-15: 9.3M2024-08-30: 10.0M2024-09-13: 10.0M2024-09-30: 9.3M2024-10-15: 9.6M2024-10-31: 7.8M
    the 31 Oct 2024 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  26. 7 Nov 2024Filings record

    Director or officer change

  27. 25 Oct 2024Short interest and volume change

    had 9.6M shares sold short in the 15 Oct 2024 report, 2.5× the same report last year.

    Same report last year: 3.9M; its normal report is 3.9M.

    See the evidence
    This period
    9.6M (the 15 Oct 2024 report)
    Normal report (median of 24 earlier)
    3.9M
    Typical spread (median absolute deviation)
    443K
    How far from its usual level
    +8.7
    Same report last year
    3.9M
    History used
    1,537 days
    2023-10-13: 3.9M2023-10-31: 3.8M2023-11-15: 3.9M2023-11-30: 3.9M2023-12-15: 4.0M2023-12-29: 3.8M2024-01-12: 3.7M2024-01-31: 3.6M2024-02-15: 3.5M2024-02-29: 3.5M2024-03-15: 2.9M2024-03-28: 3.1M2024-04-15: 3.7M2024-04-30: 3.2M2024-05-15: 3.4M2024-05-31: 2.9M2024-06-14: 4.2M2024-06-28: 5.5M2024-07-15: 7.8M2024-07-31: 9.1M2024-08-15: 9.3M2024-08-30: 10.0M2024-09-13: 10.0M2024-09-30: 9.3M2024-10-15: 9.6M
    the 15 Oct 2024 report24 earlier reportsnormal: 3.9M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 10 Oct 2024Short interest and volume change

    had 9.3M shares sold short in the 30 Sep 2024 report, 3.5× the same report last year.

    Same report last year: 2.7M; its normal report is 3.8M.

    See the evidence
    This period
    9.3M (the 30 Sep 2024 report)
    Normal report (median of 24 earlier)
    3.8M
    Typical spread (median absolute deviation)
    438K
    How far from its usual level
    +8.5
    Same report last year
    2.7M
    History used
    1,522 days
    2023-09-29: 2.7M2023-10-13: 3.9M2023-10-31: 3.8M2023-11-15: 3.9M2023-11-30: 3.9M2023-12-15: 4.0M2023-12-29: 3.8M2024-01-12: 3.7M2024-01-31: 3.6M2024-02-15: 3.5M2024-02-29: 3.5M2024-03-15: 2.9M2024-03-28: 3.1M2024-04-15: 3.7M2024-04-30: 3.2M2024-05-15: 3.4M2024-05-31: 2.9M2024-06-14: 4.2M2024-06-28: 5.5M2024-07-15: 7.8M2024-07-31: 9.1M2024-08-15: 9.3M2024-08-30: 10.0M2024-09-13: 10.0M2024-09-30: 9.3M
    the 30 Sep 2024 report24 earlier reportsnormal: 3.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  29. 4 Oct 2024Filings record

    Director or officer change

  30. 25 Sep 2024Short interest and volume change

    had 10.0M shares sold short in the 13 Sep 2024 report, 3.3× the same report last year.

    Same report last year: 3.0M; its normal report is 3.7M.

    See the evidence
    This period
    10.0M (the 13 Sep 2024 report)
    Normal report (median of 24 earlier)
    3.7M
    Typical spread (median absolute deviation)
    438K
    How far from its usual level
    +9.6
    Same report last year
    3.0M
    History used
    1,505 days
    2023-09-15: 3.0M2023-09-29: 2.7M2023-10-13: 3.9M2023-10-31: 3.8M2023-11-15: 3.9M2023-11-30: 3.9M2023-12-15: 4.0M2023-12-29: 3.8M2024-01-12: 3.7M2024-01-31: 3.6M2024-02-15: 3.5M2024-02-29: 3.5M2024-03-15: 2.9M2024-03-28: 3.1M2024-04-15: 3.7M2024-04-30: 3.2M2024-05-15: 3.4M2024-05-31: 2.9M2024-06-14: 4.2M2024-06-28: 5.5M2024-07-15: 7.8M2024-07-31: 9.1M2024-08-15: 9.3M2024-08-30: 10.0M2024-09-13: 10.0M
    the 13 Sep 2024 report24 earlier reportsnormal: 3.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  31. 12 Sep 2024Short interest and volume change

    had 10.0M shares sold short in the 30 Aug 2024 report, 3.2× the same report last year.

    Same report last year: 3.2M; its normal report is 3.7M.

    See the evidence
    This period
    10.0M (the 30 Aug 2024 report)
    Normal report (median of 24 earlier)
    3.7M
    Typical spread (median absolute deviation)
    441K
    How far from its usual level
    +9.6
    Same report last year
    3.2M
    History used
    1,491 days
    2023-08-31: 3.2M2023-09-15: 3.0M2023-09-29: 2.7M2023-10-13: 3.9M2023-10-31: 3.8M2023-11-15: 3.9M2023-11-30: 3.9M2023-12-15: 4.0M2023-12-29: 3.8M2024-01-12: 3.7M2024-01-31: 3.6M2024-02-15: 3.5M2024-02-29: 3.5M2024-03-15: 2.9M2024-03-28: 3.1M2024-04-15: 3.7M2024-04-30: 3.2M2024-05-15: 3.4M2024-05-31: 2.9M2024-06-14: 4.2M2024-06-28: 5.5M2024-07-15: 7.8M2024-07-31: 9.1M2024-08-15: 9.3M2024-08-30: 10.0M
    the 30 Aug 2024 report24 earlier reportsnormal: 3.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  32. 27 Aug 2024Short interest and volume change

    had 9.3M shares sold short in the 15 Aug 2024 report, 3.1× the same report last year.

    Same report last year: 3.0M; its normal report is 3.7M.

    See the evidence
    This period
    9.3M (the 15 Aug 2024 report)
    Normal report (median of 24 earlier)
    3.7M
    Typical spread (median absolute deviation)
    441K
    How far from its usual level
    +8.6
    Same report last year
    3.0M
    History used
    1,476 days
    2023-08-15: 3.0M2023-08-31: 3.2M2023-09-15: 3.0M2023-09-29: 2.7M2023-10-13: 3.9M2023-10-31: 3.8M2023-11-15: 3.9M2023-11-30: 3.9M2023-12-15: 4.0M2023-12-29: 3.8M2024-01-12: 3.7M2024-01-31: 3.6M2024-02-15: 3.5M2024-02-29: 3.5M2024-03-15: 2.9M2024-03-28: 3.1M2024-04-15: 3.7M2024-04-30: 3.2M2024-05-15: 3.4M2024-05-31: 2.9M2024-06-14: 4.2M2024-06-28: 5.5M2024-07-15: 7.8M2024-07-31: 9.1M2024-08-15: 9.3M
    the 15 Aug 2024 report24 earlier reportsnormal: 3.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  33. 10 Aug 2024Short interest and volume change

    had 9.1M shares sold short in the 31 Jul 2024 report, 3.1× the same report last year.

    Same report last year: 3.0M; its normal report is 3.6M.

    See the evidence
    This period
    9.1M (the 31 Jul 2024 report)
    Normal report (median of 24 earlier)
    3.6M
    Typical spread (median absolute deviation)
    416K
    How far from its usual level
    +8.9
    Same report last year
    3.0M
    History used
    1,461 days
    2023-07-31: 3.0M2023-08-15: 3.0M2023-08-31: 3.2M2023-09-15: 3.0M2023-09-29: 2.7M2023-10-13: 3.9M2023-10-31: 3.8M2023-11-15: 3.9M2023-11-30: 3.9M2023-12-15: 4.0M2023-12-29: 3.8M2024-01-12: 3.7M2024-01-31: 3.6M2024-02-15: 3.5M2024-02-29: 3.5M2024-03-15: 2.9M2024-03-28: 3.1M2024-04-15: 3.7M2024-04-30: 3.2M2024-05-15: 3.4M2024-05-31: 2.9M2024-06-14: 4.2M2024-06-28: 5.5M2024-07-15: 7.8M2024-07-31: 9.1M
    the 31 Jul 2024 report24 earlier reportsnormal: 3.6M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  34. 6 Aug 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  35. 6 Aug 2024Filings record

    Director or officer change

  36. 25 Jul 2024Short interest and volume change

    had 7.8M shares sold short in the 15 Jul 2024 report, 2.7× the same report last year.

    Same report last year: 2.9M; its normal report is 3.5M.

    See the evidence
    This period
    7.8M (the 15 Jul 2024 report)
    Normal report (median of 24 earlier)
    3.5M
    Typical spread (median absolute deviation)
    396K
    How far from its usual level
    +7.2
    Same report last year
    2.9M
    History used
    1,445 days
    2023-07-14: 2.9M2023-07-31: 3.0M2023-08-15: 3.0M2023-08-31: 3.2M2023-09-15: 3.0M2023-09-29: 2.7M2023-10-13: 3.9M2023-10-31: 3.8M2023-11-15: 3.9M2023-11-30: 3.9M2023-12-15: 4.0M2023-12-29: 3.8M2024-01-12: 3.7M2024-01-31: 3.6M2024-02-15: 3.5M2024-02-29: 3.5M2024-03-15: 2.9M2024-03-28: 3.1M2024-04-15: 3.7M2024-04-30: 3.2M2024-05-15: 3.4M2024-05-31: 2.9M2024-06-14: 4.2M2024-06-28: 5.5M2024-07-15: 7.8M
    the 15 Jul 2024 report24 earlier reportsnormal: 3.5M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  37. 25 Jun 2024Insiders record

    GARCIA PETER S (CHIEF FINANCIAL OFFICER) bought 12,000 shares of ALXO [amended] [same transaction as an earlier filing] (dated 24 Jun 2024)

  38. 18 Jun 2024Insiders record

    GARCIA PETER S (CHIEF FINANCIAL OFFICER) bought 12,000 shares of ALXO ($102,360) (dated 17 Jun 2024)

  39. 2 May 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  40. 2 May 2024Filings record

    Director or officer change

Showing the newest 40 of 75 entries; narrow the window or the kind of data to see older ones.

Not listed: 142 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001810182
Ticker
ALXO
Domain
alxoncology.com
Hq location
CA|SOUTH SAN FRANCISCO|94080 (1 unverified)
Name
ALX Oncology Holdings Inc.
  • SEC Form 13F institutional holdings225 data points30 Sep 2020 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)99 records26 Jun 2020 to 16 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)417 data points31 Dec 2017 to 9 Nov 2026
  • SEC Form 4 insider transactions87 records, 228 data points21 Jul 2020 to 18 Aug 2026
  • FINRA short interest (twice monthly)449 data points31 Jul 2020 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)3192 data points17 Jul 2020 to 20 Nov 2026